Italy to increase tobacco prices in 2023

Dec.27.2022
Italian tobacco products will face a price hike in 2023 due to tax changes, affecting cigarette and e-cigarette users.

Smokers in Italy received some bad news as tobacco products will experience a price hike in 2023. The reason for this is due to a revision included in the 2023 budget law, which aims to reshuffle consumption taxes between different products through changes in taxes.

 

As we mentioned earlier, tobacco product users can expect to see a hike in the prices of their vice in 2023. According to the latest developments, a provision increasing the specific consumption tax on cigarettes has been approved by the executive branch led by President Meloni in the 2023 Budget Act. Starting January 1st, 2023, each pack of cigarettes will see a price increase of €0.20 (approximately RMB 1.48), with varying degrees of increment depending on the brand.

 

But that's not all. In 2024, the increase in cigarette prices will continue, with an additional raise of 0.10 or 0.15 euros after the growth in 2023. In other words, starting in 2024, cigarettes may cost an extra 35 cents (about 2.24 yuan) per pack.

 

In 2023, the growth is not only targeted at cigarette users, but also affects those who use electronic cigarettes, such as heated tobacco. However, for this type of cigarette, the increase in price is relatively small, with non-nicotine cigarettes costing approximately 0.08 euros per milliliter (about 0.59 yuan), while nicotine-containing cigarettes will rise to 0.13 euros (about 0.96 yuan).

 

The government's recent estimate projects that Italy could collect at least 100 million euros annually as the price of cigarettes and tobacco is set to increase by 2023.

 

It has been announced that cigarettes and tobacco will increase in price in 2023, but what will their prices be in 2021, with the introduction of the euro? The official website of the State Monopoly Agency for Customs and Excise has released a list of cigarette prices, including all brands available to the public, updated as of November 24th of this year. We can see that in 2022, a pack of cigarettes will cost between 4.8 and 6 euros.

 

Considering the rise in cigarette and tobacco prices in 2023, lower-priced cigarette packs may need to cost 5 euros, while higher-priced packs could even cost 6.20 euros. But what were cigarette prices in 2001? At that time, MS cost 2.17 euros, Camel increased to 2.48 euros, and the most popular brand, Marlboro, was priced at 3 euros. In short, over the last 20 years, cigarette prices have increased by more than 2 euros.

 

Let's take a look at who will spend more money next year in Italy, as cigarettes and tobacco prices are set to increase in 2023.

 

According to data analysis from Epicentre ISS, we can estimate that Italian regions will spend more money on cigarette and tobacco packaging next year due to the Meloni government's plan to increase prices in 2023, based on a two-year period from 2020-2021.

 

In Italy, where do people smoke the most? Among the regions with the highest smoking rates, the top ranking is held by certain areas in central and southern Italy, particularly Abruzzo, Umbria, and Campania, but there are also significant numbers of smokers in Emilia-Romagna.

 

On the contrary, in 2023, the regions of Puglia, Marche, Calabria and Friuli-Venezia Giulia will be less affected by the increase in cigarette and tobacco prices.

 

Data from the Istituto Superiore di Sanità reveals that in Italy, 50% of the population does not smoke, while 24.5% have a habitual consumption of cigarettes.

 

With the awareness that cigarettes and tobacco will increase in price in 2023, let's take a look at how much revenue the country generates from cigarette sales. In this scenario, data from 2020 from the demographic analysis institution, Eurispes, reveal that the country collects approximately 14 billion euros yearly from cigarette sales.

 

However, it is important to note that if we consider the expenses borne by the country itself on an annual basis to support public health measures, prevent and treat diseases related to tobacco consumption, the net profit is actually half of this figure, approximately 7 billion euros.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23